Australia
Cipla Australia has a vast pipeline of products that are supplied in Australia as well as US & EU. Millions of Australians have access to a Cipla manufactured product through our community pharmacy partners around Australia.
Our state-of-the-art manufacturing facilities are TGA approved as well as being USFDA (USA) and MHRA (UK) approved. Cipla Australia has over 200 registered formulations with TGA through partnerships with market leaders and on its own. The list of registered medicines includes OTC (Over the Counter), Prescription and hospital medicines. We are also involved in helping Australians access medicines through the SAS (Special Access Scheme). Cipla has earned a name for maintaining world-class quality across all our manufacturing units, products and services. Globally, our patent filing includes drug substances, drug products, platform technologies, IP on polymorphs and crystallinity, and medical devices.
Quick Facts
Australian Presence
2000
Employees
30+
Product Registrations
500+
Cipla Deferasirox Educational materials
Cipla Ambrisentan Educational materials
Cipla Adalimumab Educational materials
Cipla Lenalidomide Educational materials
-
Cipla Lenalidomide Information Brochure for HCP
-
Cipla Lenalidomide Patient Brochure
-
Cipla Lenalidomide Patient card
-
Cipla Lenalidomide Initiation Checklist - Combined
-
Cipla Lenalidomide Treatment Initiation Form-Male Patients
-
Cipla Lenalidomide Treatment Initiation Form-Women of Child bearing Potential
-
Cipla Lenalidomide Treatment Initiation Form - Women of Non-Child bearing Potential
-
Cipla Lenalidomide Pharmacy Registration Form
-
Cipla Lenalidomide Prescription Authorisation Form
-
Cipla Lenalidomide Adverse Event Form
-
Cipla Lenalidomide Pregnancy Outcome Form
-
Cipla Lenalidomide Pregnancy Reporting Form
-
Cipla Lenalidomide caregiver guide
Cipla Fingolimod Educational materials
Cipla Australia Pty Ltd,
Level 1, 132 - 136 Albert Road,
South Melbourne, VIC 3205
Phone : +613 9696 4438
Drug Safety Reporting in Australia
1800-569-074
Phone: +91 821-6643551 (Except US and EU)
Email : drugsafety@cipla.com
Office, HR and Operations enquiries
Ragda Harmouche
Ragda.harmouche@cipla.com
Cipla has a long heritage of being a world leader in Respiratory Therapy - India, South Africa and various Emerging Markets to name a few. In keeping with our purpose of ‘Caring for Life’, we are constantly working towards improving patient access to necessary and innovative medicines for better management of diseases and improved quality of life. We pride ourselves in having the world’s largest respiratory range of drugs, dosage forms and devices for COPD and Asthma. Our products are available in more than 80+ countries worldwide. Key products were successfully launched in many European countries e.g. UK, Germany, Belgium, Netherlands, Czech Republic and Croatia.
